IGHG4
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • IMMUNE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE
  • INTERACTION
  • METABOLIC
  • ISOFORM
  • EVOLUTIONARY
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • AI IMPLEMENTATIONS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • HELP & FAQ
  • ANTIBODY AVAILABILITY
  • DISCLAIMER
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Category
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Tissue
Category
Tau score
Tissue
Category
Tau score
Cluster
Reliability
Region
Niche
Category
Brain region
Category
Tau score
Brain domain
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Cell type
Category
Tau score
Cell type group
Category
Tau score
Single cell
Category
Tau score
Single cell
Category
Tau score
Annotation
Annotation
Annotation
Tissue
Cell type
Enrichment
Cluster
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Regulation
Cancer
Regulation
Cancer
Category
Cancer
Category
Tau score
Correlation
Correlation
Cancer
Category
Tau score
Cluster
Variants
Source
PTM
ipTM
Interacting gene (ensg_id)
Type
Number of interactions
Type
Heterodimer
Subsystem
Isoforms
Specificity
Expression
Species
Ortholog
Type
Species
Tissue
Category
Species
Tau score
Data
Category
Data
Species
Category
Category
Category
Category
Category
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


BETA
  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • IMMUNE

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCTURE

  • INTERACTION

  • METABOLIC

  • ISOFORM

  • EVOLUTION

  • IGHG4
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
Hippocampal formation Amygdala Basal ganglia Midbrain Spinal cord Cerebral cortex Cerebellum Hypothalamus Choroid plexus Retina Thyroid gland Parathyroid gland Adrenal gland Pituitary gland Lung Salivary gland Esophagus Tongue Stomach Rectum Colon Duodenum Small intestine Liver Gallbladder Pancreas Kidney Urinary bladder Testis Epididymis Prostate Seminal vesicle Vagina Breast Cervix Endometrium Fallopian tube Ovary Placenta Blood vessel Heart muscle Skeletal muscle Smooth muscle Adipose tissue Skin Bone marrow Lymph node Tonsil Spleen Appendix Thymus
IGHG4 INFORMATION
Proteini

Full gene name according to HGNC.

Immunoglobulin heavy constant gamma 4 (G4m marker)
Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

IGHG4
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

FDA approved drug targets
Immunoglobulin genes
Plasma proteins
Protein evidence Evidence at protein level (all genes)
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

2
Protein interactions Interacting with 21 proteins
IGHG4 AI GENERATED INFOGRAPHICi

This infographic was generated by AI (Gemini) using only data presented in the Human Protein Atlas v25. It is a quick overview and may contain errors or simplifications, so please check the full data on this gene page before drawing conclusions.

Read more
PROTEIN EXPRESSION AND LOCALIZATION
Tissue profilei

A summary of the overall protein expression profile across the analyzed normal tissues based on knowledge-based annotation, presented in the Tissue resource.

"Estimation of protein expression could not be performed. View primary data." is shown for genes where available RNA-seq and gene/protein characterization data in combination with immunohistochemistry data has been evaluated as not sufficient to yield a reliable estimation of the protein expression profile.

Cytoplasmic and plasma protein expression in several tissues.
Tissue specificity (MS) Tissue enhanced (Lung)
Cell type specificity (DVP) Low cell type specificity
Subcellular locationi

Main subcellular location based on data generated in the subcellular section of the Human Protein Atlas.

Not available
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.
  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Secreted, Membrane, Intracellular (different isoforms)
TISSUE RNA EXPRESSION
Tissue specificityi

The RNA specificity category is based on normalized mRNA expression levels in the consensus dataset, calculated from the RNA expression levels in samples from HPA and GTEX. The categories include: tissue enriched, group enriched, tissue enhanced, low tissue specificity and not detected.

Tissue enriched (Lymphoid tissue)
Tissue expression clusteri

The RNA data was used to cluster genes according to their expression across tissues. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Lymphoid tissue - Immune response (mainly)
Brain specificityi

The regional specificity category is based on mRNA expression levels in the analysed brain samples, grouped into 13 main brain regions and calculated for the three different species. All brain expression profiles are based on data from HPA. The specificity categories include: regionally enriched, group enriched, regionally enhanced, low regional specificity and not detected. The classification rules are the same used for the tissue specificity category

Domain enhanced (Pons, Spinal cord gray matter)
Brain expression clusteri

The RNA data was used to cluster genes according to their expression across tissues. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Hindbrain - Mixed function (mainly)
Isoform expression categoryi

The expression category reflects the overall expression pattern for the gene based on expression profiles for all individual isoforms.

Read more
Dominant isoform, all expressed
Evolutionary conservation categoryi

Conservation category is a categoric annotation that intends to capture the available pairwise species overlap annotations into one metric. The categories range from: Complete, Partial and Minimal Conservation for conserved genes; and Tissue elevation shift, human specific tissue elevated, Non-Human tissue elevated, Human specific detected and Human not detected for non conserved genes.

No 1-to-1 orthologs
CELL TYPE RNA EXPRESSION
Single cell type specificityi

The RNA specificity category is based on mRNA expression levels in the analyzed cell types based on scRNA-seq data from normal tissues. The categories include: cell type enriched, group enriched, cell type enhanced, low cell type specificity and not detected.

Cell type enriched (Plasma cells)
Single cell type
expression clusteri

The RNA data was used to cluster genes according to their expression across single cell types. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Plasma cells - Antibody production & secretion (mainly)
Bulk RNA deconvolution classificationi

Genes can have enriched specificity in different cell types in one or several tissues, or be enriched in a core cell type that appears in many different tissues.

Core cell type enriched (Plasma cells)
Immune cell specificityi

The RNA specificity category is based on mRNA expression levels in the analyzed samples based on data from HPA. The categories include: cell type enriched, group enriched, cell type enhanced, low cell type specificity and not detected.

Group enriched (memory B-cell, naive B-cell)
Immune cell
expression clusteri

The RNA data was used to cluster genes according to their expression across single cell types. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

B-cells - Immunoglobulins (mainly)
CANCER & CELL LINES
Cancer specificity (RNA)i

Specificity of RNA expression (TCGA dataset) across 21 cancer types is categorized as either cancer enriched, group enriched, cancer enhanced, low cancer specificity or not detected.

Low cancer specificity
Cancer specificity (Protein)i

Specificity of protein abundance in tumor samples from 25 cancer types, measured by mass spectrometry (ProteinTalks DB dataset), is categorized as cancer enriched, group enriched, cancer enhanced, low cancer specificity or not detected.

Not detected
Cell line
expression clusteri

The RNA data was used to cluster genes according to their expression across cell lines. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Lymphoma - Humoral immune response (mainly)
Cell line specificityi

RNA specificity category based on RNA sequencing data from cancer cell lines in the Human Protein Atlas grouped according to type of cancer. Genes are classified into six different categories (enriched, group enriched, enhanced, low specificity and not detected) according to their RNA expression levels across the panel of cell lines.

Group enriched (Lymphoma, Myeloma)
PROTEINS IN BLOOD
Detected in blood by
immunoassayi

The blood-based immunoassay category applies to actively secreted proteins and is based on plasma or serum protein concentrations established with enzyme-linked immunosorbent assays, compiled from a literature search. The categories include: detected and not detected, where detection refers to a concentration found in the literature search.

No (not applicable)
Detected in blood by
mass spectrometryi

Detection or not of the gene in blood, based on spectral count estimations from a publicly available mass spectrometry-based plasma proteomics dataset obtained from the PeptideAtlas.

No
Proximity extension assayi

Indicates whether the protein has been measured (Data available) or not (Not available) using the Olink Explore HT proximity extension assay platform.

Not available
SomaScani

Indicates whether the protein has been measured (Data available) or not (Not available) using the SomaScan 11K platform.

Data available
PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) 1, 2, 3. The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure 4, 5, 6. The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE 7, 8, 9. The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.... show less
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Adaptive immunity, Immunity

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
KAW logo The Human Protein Atlas project is funded
by the Knut and Alice Wallenberg Foundation.

Facebook logo X logo Bluesky logo Linkedin logo RSS feed logo contact@proteinatlas.org
GCBR logo Elixir core logo SciLifeLab logo Uppsala university logo KI logo KTH logo
We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.